Audra Moran, President & CEO of OCRA, joined Katie Couric to explain important new developments around symptoms and early detection of ovarian cancer, and what this means for the future. … Continued
OCRA is pleased to award $7 million in ovarian cancer research funding for 2023, representing the largest annual research investment in our history. With this funding, 20 cancer researchers at 15 medical institutions … Continued
OCRA’s President & CEO, Audra Moran, spoke with CBS New York about the newest ovarian cancer risk and prevention updates, in an important segment timed to Ovarian Cancer Awareness Month.
An article published on February 2nd in The Washington Post highlights a turning point in our fight against ovarian cancer. As covered in the article, “Fallopian tube removal advised for more women … Continued
An article published on February 1st in The New York Times highlights a turning point in our fight against ovarian cancer. As covered in the article, “To Prevent Cancer, More … Continued
Today marks a turning point in our fight against ovarian cancer. As covered in The New York Times, we are launching an important campaign centered around two messages with proven … Continued
[NEW YORK, Feb. 1, 2023] — In a dramatic shift of focus in the fight against ovarian cancer, Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian cancer organization, today announced they will begin … Continued
Finding a method of early detection for ovarian cancer has been a primary focus of research for years, and was believed to be a promising approach to stopping women, or … Continued
OCRA is pleased to award research prizes to Dr. Ursula Matulonis and Dr. Pradeep Chaluvally-Raghavan, two investigators doing groundbreaking and important work in the field of ovarian cancer research. OCRA’s … Continued
Many people talk about New Year’s resolutions in the month of January, which is all well and good. But sometimes these long-range goals don’t exactly stick. Why not focus on … Continued
A recent study, funded in part by OCRA, has shed new light on how the most common subtype of ovarian cancer develops and metastasizes, by identifying a key molecule that … Continued
As immunotherapies have seen rising success in treating several other cancers, researchers are hard at work uncovering why immunotherapy for ovarian cancer has, so far, proven ineffective. In a study … Continued
Get email updates about research news, action alerts, and ways to join the fight.
